Siemens IMMULITE Gastrin Assay Recalled for Biotin Interference
Siemens Healthcare Diagnostics is recalling IMMULITE Gastrin assays because biotin interference is not listed in the instructions for use.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a moderate severity score. The hazard is a labeling omission regarding biotin interference limits, which is a documentation issue rather than a direct physical defect or reported injury.
Plain-English summary
Siemens Healthcare Diagnostics, Inc. is recalling the IMMULITE 2000/IMMULITE 2000 XPi Gastrin assays. The recall is due to the fact that the concentrations of biotin that do not interfere with the test are not currently listed in the instruction for use.
The source text indicates that these assays are susceptible to interference from biotin. This recall is part of a broader issue affecting several other Siemens assays, including Dimension Vista and ADVIA Centaur products, where biotin interference limits are not documented.
The affected products were distributed nationwide in the United States, as well as in Canada, Mexico, and Thailand. The specific lot codes involved are 251, 252, 253, 254, and 255. Users of these medical devices should consult the manufacturer for further instructions on handling the recalled units.
The recalled product
- Product
- IMMULITE ¿ 2000/IMMULITE ¿ 2000 XPi Gastrin
- Manufacturer
- Siemens Healthcare Diagnostics, Inc.
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Gastrin
- Gastrin (IMMULITE/IMMULITE 1000
- LKGA1)
- (IMMULITE 2000/IMMULITE 2000 XPi
- LKGA2) Lot codes: 251 252 253 254 255
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 24 recalled by Siemens Healthcare Diagnostics, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 24 products in this recall →Related recalls
Same manufacturer · Siemens Healthcare Diagnostics, Inc.
See all →- SevereSiemens Recalls Emit 2000 Quinidine Assay Due to Precision Issues
FDA (Devices) · 2026-08-26
- SevereSiemens Quinidine Assay Recalled for Precision Errors
FDA (Devices) · 2026-08-26
- HighSiemens Atellica CH Urine Albumin In Vitro Diagnostic Recall
FDA (Devices) · 2026-08-12
- ModerateSiemens Tricyclic Antidepressant Calibrator/Controls Recall Lot U2
FDA (Devices) · 2026-08-12
- LowSyva Emit Disopyramide Enzyme Immunoassay Calibrator Recalled for Sodium Azide Concentration
FDA (Devices) · 2026-08-12
Same hazard · biotin interference
See all →- ModerateBeckman Coulter Free T3 Immunoassay Recalled for Biotin Interference
FDA (Devices) · 2020-06-10
- HighBeckman Coulter Access Free T4 Thyroxine Assay Recalled for Biotin Interference
FDA (Devices) · 2020-06-10
- HighBeckman Coulter Access Thyroglobulin Antibody II Recalled for Biotin Interference
FDA (Devices) · 2020-06-10
- ModerateBeckman Coulter Access GI Monitor Cancer Antigen 19-9 Recalled for Biotin Interference
FDA (Devices) · 2020-06-10
- ModerateBeckman Coulter Access Thyroglobulin Immunoassay Recalled for Biotin Interference
FDA (Devices) · 2020-06-10